Skip to main content
. 2006 Apr 21;61(6):706–715. doi: 10.1111/j.1365-2125.2006.02643.x

Table 2.

SLCO1B1 and ABCB1 genotypes in 20 children with heterozygous familial hypercholesterolaemia (HeFH) and in 12 paediatric cardiac transplant recipients

Gene Region Position Allele Patients with HeFH n (%) Transplant recipients n (%) Genotype Patients with HeFH n (%) Transplant recipients n (%)
SLCO1B1 Promoter −11187 G 38 (95%) 24 (100%) GG 18 (90%) 12 (100%)
A  2 (5%)  0 (0%) GA  2 (10%)  0 (0%)
SLCO1B1 Exon 5    521 T 34 (85%) 21 (88%) TT 14 (70%)  9 (75%)
C  6 (15%)  3 (13%) TC  6 (30%)  3 (25%)
ABCB1 Exon 21   2677 G 17 (43%) 15 (63%) GG  4 (20%)  5 (42%)
T 21 (53%)  8 (33%) GT  8 (40%)  5 (42%)
A  2 (5%)  1 (4%) TT  6 (30%)  1 (8%)
GA  1 (5%)  0 (0%)
TA  1 (5%)  1 (8%)
ABCB1 Exon 26   3435 C 20 (50%) 13 (54%) CC  5 (25%)  3 (25%)
T 20 (50%) 11 (46%) CT 10 (50%)  7 (58%)
TT  5 (25%)  2 (17%)

Positions of SNPs correspond to their positions in the cDNA (exonic SNPs) or genomic sequence (promoter SNP) with the first base of the ATG first codon set to 1.